BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30146577)

  • 1. The Progression of Esophageal Mucosa-associated Lymphoid Tissue Lymphoma after Helicobacter pylori Eradication Therapy: A Case Report and Discussion of Therapeutic Options.
    Takeuchi Y; Miyahara K; Morito T; Okikawa Y; Kinugasa H; Moritou Y; Higashi R; Kunihiro M; Nakagawa M
    Intern Med; 2019 Jan; 58(2):207-212. PubMed ID: 30146577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of the Colon: A Case Report and a Literature Review.
    Abbas H; Niazi M; Makker J
    Am J Case Rep; 2017 May; 18():491-497. PubMed ID: 28469125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
    Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
    Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
    Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
    Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
    Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
    Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of superficial gastric MALT lymphoma with unsuccessful eradication therapy for Helicobacter pylori infection.
    Yoshikane H; Yokoi T; Hidano H; Sakakibara A; Niwa Y; Goto H
    J Gastroenterol; 1997 Dec; 32(6):812-6. PubMed ID: 9430022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication therapy is effective for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma.
    Asano N; Iijima K; Terai S; Jin X; Ara N; Chiba T; Fushiya J; Koike T; Imatani A; Shimosegawa T
    Tohoku J Exp Med; 2012 Nov; 228(3):223-7. PubMed ID: 23076291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
    Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
    Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
    Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
    Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
    Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
    Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
    Chen LT; Lin JT; Shyu RY; Jan CM; Chen CL; Chiang IP; Liu SM; Su IJ; Cheng AL
    J Clin Oncol; 2001 Nov; 19(22):4245-51. PubMed ID: 11709568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasmacytic differentiation in gastric mucosa-associated lymphoid tissue lymphomas: Helicobacter pylori eradication response and IgG4+ plasma cell association.
    Park S; Ahn S; Hong M; Ko YH
    Hum Pathol; 2017 Jan; 59():113-119. PubMed ID: 27697589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in pattern of immunoglobulin heavy chain gene rearrangement and MIB-1 staining before and after eradication of Helicobacter pylori in gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
    Kanda M; Suzumiya J; Ohshima K; Okada M; Tamura K; Kikuchi M
    Leuk Lymphoma; 2001 Aug; 42(4):639-47. PubMed ID: 11697492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
    Hong SS; Jung HY; Choi KD; Song HJ; Lee GH; Oh TH; Jo JY; Kim KJ; Byeon JS; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI
    Helicobacter; 2006 Dec; 11(6):569-73. PubMed ID: 17083379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy.
    Caletti G; Togliani T; Fusaroli P; Sabattini E; Khodadadian E; Gamberi B; Gobbi M; Pileri S
    Gastroenterology; 2003 Feb; 124(2):537-43. PubMed ID: 12557157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric MALT-lymphoma, gastrin and cyclooxygenases.
    Konturek PC; Konturek SJ; Pierzchalski P; Starzyńska T; Marlicz K; Hartwich A; Zuchowicz M; Darasz Z; Papiez D; Hahn EG
    Acta Gastroenterol Belg; 2002; 65(1):17-23. PubMed ID: 12014312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series.
    Fischbach W; Goebeler ME; Ruskone-Fourmestraux A; Wündisch T; Neubauer A; Raderer M; Savio A;
    Gut; 2007 Dec; 56(12):1685-7. PubMed ID: 17639089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.